Expertise in
1
conditions

Dr. Daneshvari Solanki

Anesthesiology
University Of Texas Medical Branch
301 University Blvd, 
Galveston, TX 
Expertise in
1
conditions
University Of Texas Medical Branch
301 University Blvd, 
Galveston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daneshvari Solanki is an Anesthesiologist in Galveston, Texas. Dr. Solanki is highly rated in 1 condition, according to our data. His top areas of expertise are Phantom Limb Pain, Abdominal Wall Surgery, and Knee Replacement.

His clinical research consists of co-authoring 21 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Anesthesiology
Licenses
Anesthesiology in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

University of Texas Medical Branch
301 University Blvd, Galveston, TX 77555

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain
An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drugs: Qutenza (Capsaicin) 8% Topical System, Capsaicin 0.04% Topical System
Study Phase: Phase 3
Healing Osteoarthritic Joints in the Wrist With Adult Adipose Derived Regenerative Cells
Healing Osteoarthritic Joints in the Wrist With Adult Adipose Derived Regenerative Cells
Enrollment Status: Active_not_recruiting
Publish Date: August 20, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Prospective, Double-Blinded, Multi-Center Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
A Prospective, Double-Blinded, Multi-Center Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
Enrollment Status: Active_not_recruiting
Publish Date: August 20, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Two-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics and Preliminary Efficacy Study of CA-008 in Patients Undergoing Total Knee Arthroplasy
A Two-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics and Preliminary Efficacy Study of CA-008 in Patients Undergoing Total Knee Arthroplasy
Enrollment Status: Completed
Publish Date: May 08, 2024
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Prospective, Multicenter, Randomized, Double-Blinded, Sham-Control Study to Evaluate the Efficacy and Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
A Prospective, Multicenter, Randomized, Double-Blinded, Sham-Control Study to Evaluate the Efficacy and Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
Enrollment Status: Completed
Publish Date: October 06, 2023
Intervention Type: Combination product, Other
Study Drug: Clonidine Micropellets
Study Phase: Phase 3
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen
A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen
Enrollment Status: Terminated
Publish Date: January 25, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Randomized, Active and Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis
A Phase 2, Randomized, Active and Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis
Enrollment Status: Unknown
Publish Date: January 17, 2023
Intervention Type: Drug
Study Drugs: Resiniferatoxin, Zilretta
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo- and Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Combination of Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy
A Phase 2, Randomized, Double-Blind, Placebo- and Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Combination of Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 2, Randomized, Double-blind, Placebo-controlled Safety, Pharmacokinetics and Efficacy Study of CA-008 in Subjects Undergoing Bunionectomy
A Phase 2, Randomized, Double-blind, Placebo-controlled Safety, Pharmacokinetics and Efficacy Study of CA-008 in Subjects Undergoing Bunionectomy
Enrollment Status: Completed
Publish Date: August 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Comparative Effectiveness Randomized Controlled Trial of SPR Peripheral Nerve Stimulation (PNS) Therapy for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Utilizing Preoperative Lead Placement
A Prospective, Comparative Effectiveness Randomized Controlled Trial of SPR Peripheral Nerve Stimulation (PNS) Therapy for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Utilizing Preoperative Lead Placement
Enrollment Status: Completed
Publish Date: May 12, 2021
Intervention Type: Device
Study Phase: Not Applicable
Phase 1b Double-blind Study to Assess the Safety, Tolerability and Preliminary Efficacy of Intra-articular Administration of Resiniferatoxin Versus Placebo for the Treatment of Pain Due to Moderate to Severe Osteoarthritis of the Knee
Phase 1b Double-blind Study to Assess the Safety, Tolerability and Preliminary Efficacy of Intra-articular Administration of Resiniferatoxin Versus Placebo for the Treatment of Pain Due to Moderate to Severe Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: April 01, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Multicenter, Open-Label, Phase 1b Study to Assess the Safety and Define the Maximally Tolerated Dose of Epidural Resiniferatoxin Injection for the Treatment of Intractable Pain Associated With Cancer
A Multicenter, Open-Label, Phase 1b Study to Assess the Safety and Define the Maximally Tolerated Dose of Epidural Resiniferatoxin Injection for the Treatment of Intractable Pain Associated With Cancer
Enrollment Status: Completed
Publish Date: October 20, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 12 Less Clinical Trials

21 Total Publications

Suzetrigine, a Nonopioid Na V 1.8 Inhibitor for Treatment of Moderate-to-severe Acute Pain: Two Phase 3 Randomized Clinical Trials.
Suzetrigine, a Nonopioid Na V 1.8 Inhibitor for Treatment of Moderate-to-severe Acute Pain: Two Phase 3 Randomized Clinical Trials.
Journal: Anesthesiology
Published: March 21, 2025
Similar Doctors
Expertise in
2
conditions
Dr. Harold Minkowitz
Anesthesiology
Expertise in
2
conditions
Dr. Harold Minkowitz
Anesthesiology

U. S. Anesthesia Partners Of Texas P.A.

1500 Citywest Blvd Ste 300, 
Houston, TX 
 (32.8 miles away)
972-233-1999
Languages Spoken:
English
See accepted insurances

Harold Minkowitz is an Anesthesiologist in Houston, Texas. Dr. Minkowitz is highly rated in 2 conditions, according to our data. His top areas of expertise are Abdominal Wall Surgery and Knee Replacement.

Expertise in
1
conditions
Dr. Arvind Chandrakantan
Anesthesiology
Expertise in
1
conditions
Dr. Arvind Chandrakantan
Anesthesiology

Texas Childrens Hospital

6621 Fannin St, 
Houston, TX 
 (23.6 miles away)
832-824-5800
Languages Spoken:
English
See accepted insurances

Arvind Chandrakantan is an Anesthesiologist in Houston, Texas. Dr. Chandrakantan is highly rated in 1 condition, according to our data. His top area of expertise is Adenoidectomy.

Expertise in
5
conditions
Dr. Salahadin Abdi
Anesthesiology
Expertise in
5
conditions
Dr. Salahadin Abdi
Anesthesiology

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
 (23.3 miles away)
713-792-6070
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Salahadin Abdi is an Anesthesiologist in Houston, Texas. Dr. Abdi is highly rated in 5 conditions, according to our data. His top areas of expertise are Neuralgia, Chronic Pain, Acute Pain, Complex Regional Pain Syndrome, and Cordotomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Solanki's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile